Universities and publicly funded research institutions will be part of the solution to the access to medicines crisis by promoting medical innovation in the public interest and ensuring that all people regardless of income have access to essential medicines and other health-related technologies.
As a non-profit organization rooted in a global movement of university students, UAEM aims to
(1) promote access to medicines and medical innovations in low- and middle-income countries by changing norms and practices around academic patenting and licensing, supported by our own independent research,
(2) ensure that university medical research meets the needs of people worldwide and
(3) empower students to respond to the access and innovation crisis.
As committed students from all over the world who passionately believe in social justice and health equity, we find it unacceptable that millions of people do not have access to essential medicines. We are particularly concerned about people in developing countries who are disproportionately affected by the access to medicines crisis.
Universities have a social compact with society and, as educational and research institutions, they have a responsibility to promote and manage the deployment of innovations for the public benefit. In no field are the moral imperatives to do so as clear as they are in medicine.
Students are uniquely positioned to push for normative change in their universities and research institutions. We will use the intellectual sophistication, rigor and integrity of our members to fight for increased innovation as well as access to medicines and health-related technologies for all.
Our work is guided at all times by principles of non-partisanship, democracy, transparency and respect.
In order to fulfill the requirements for our ANBI status you will find all the information needed in this (dutch) document:
Algemene informatie UAEM-NL
In 2001, a group of Yale University law students, together with Médecins Sans Frontières, helped convince Yale and the pharmaceutical company Bristol-Myers Squibb to permit generic production of a critical Yale-discovered HIV/AIDS drug in sub-Saharan Africa, triggering dramatic 30-fold price reductions. This was the first such concession on an HIV/AIDS drug; price cuts on other medications soon followed. This enabled a major scale-up of HIV treatment throughout the continent. The campaign showed those students that, as major contributors to drug development, universities are well positioned to influence the way medical technologies are developed and distributed, and thus can do much to help alleviate the access-to-medicines crisis.
Since this initial victory, UAEM has grown into a worldwide student organization with chapters at over 40 research universities, and a membership which includes students of medicine, science, public health, economics, and many other areas. The focus of the organization has expanded from only asking how universities can best license their innovations to promote global access, to also asking how universities can best direct and measure their research to have the greatest social impact worldwide, and promoting these ideals at the national and international levels. We work continuously to raise general awareness of these issues, and conduct independent research about them to empower our fellow students to tackle these challenges.
Read all about our current proposals and projects.